LDHA and cancer: Valproic acid (VA) is a histone deacetylase (HDAC) inhibitor regarded as a new class of anticancer agents able to protect normal cells and simultaneously sensitize cancer cells to ionizing radiation [6], and can promote the dedifferentiation of ALDH- cells into ALDH+ cells and mammosphere-forming efficiency [7].